CPI seeks patent extension on Ventak:
This article was originally published in Clinica
Executive Summary
Guidant's Cardiac Pacemakers is seeking 363 days of US patent extension for its Ventak P2 AICD system, which was approved by the FDA in March 1995. The US agency has determined that the review period for the device was 1,178 days, of which 620 were during the testing phase and 558 during the approval period.